These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1736833)

  • 21. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
    J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
    Leyvraz S; Barrelet L; Savary M; Bernasconi S
    Cancer Treat Rep; 1987 Jan; 71(1):81-2. PubMed ID: 3791271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of a phase II study with the new cytostatic drug carboplatin in combination with 5-fluorouracil in the primary treatment of advanced squamous cell cancers of the head and neck].
    Volling P; Schröder M; Rauschning W; Achterrath W; Stennert E; Nagel G
    HNO; 1988 Nov; 36(11):452-5. PubMed ID: 3069815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
    Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M; Yanagisawa T; Kishimoto H; Yoshioka W; Teranobu O; Shigeta Y; Komori T; Shimada K; Ohnishi M; Tanaka Y; Kamiya Y; Akazawa N; Oko T; Takahashi N; Adachi R; Tanigaki S; Hirata Y; Yakushiji N; Kitamura R; Hashikawa N;
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):789-95. PubMed ID: 11432346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck.
    Tulunay OE; Enamorado II; Kucuk O; Heilbrun LK; Otero JE; Korkmaz H; Blumberg R; Jacobs JR
    Head Neck; 2007 Mar; 29(3):267-71. PubMed ID: 17163471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
    Rowland KM; Taylor SG; Spiers AS; DeConti RC; O'Donnell MR; Showel J; Stott PB; Milner LM; Marsh JC
    Cancer Treat Rep; 1986 Apr; 70(4):461-4. PubMed ID: 3698038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin, vindesine, and 96-h continuous infusion of 5-fluorouracil as initial chemotherapy for locally advanced head and neck carcinoma.
    Perey L; Pasche P; Bauer J; Capasso P; Savary M; Leyvraz S
    Am J Clin Oncol; 1991 Apr; 14(2):162-5. PubMed ID: 2028924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer.
    Tellez-Bernal E; Recondo G; Guillot T; Benhamed M; Domenge C; Izzo J; Cvitkovic E; Armand JP
    Cancer; 1990 Aug; 66(4):640-4. PubMed ID: 2386892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy with CDDP and 5-FU in head and neck cancer.
    Furusaka T; Kida A; Iida H; Yokode Y; Kikuchi K; Tomita H
    Auris Nasus Larynx; 1986; 13 Suppl 1():S127-33. PubMed ID: 3021095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy prior to surgery in head and neck cancer.
    Paterson C; Robertson AG; Grose D; Correa PD; Rizwanullah M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):79-80. PubMed ID: 22070911
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group study.
    Jassem J; Gyergyay F; Kerpel-Fronius S; Nagykálnai T; Baumöhl J; Verweij J; Vuletic L; Mechl Z; Drozd-Lula M; Jelic S
    Cancer Chemother Pharmacol; 1993; 31(6):489-94. PubMed ID: 8453690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neo-adjuvant chemotherapy +/- immunotherapy with s.c. IL 2 in advanced squamous cell carcinoma of the head and neck: a pilot study.
    Mantovani G; Bianchi A; Curreli L; Ghiani M; Santona MC; Proto E; Puxeddu P
    Biotherapy; 1994; 8(2):91-8. PubMed ID: 8924357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hyponatremia with cisplatin administration in head and neck cancer patients].
    Yajima Y; Fujii M; Tokumaru Y; Habu N
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2861-5. PubMed ID: 21160261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cetuximab in head and neck cancer.
    Guntinas-Lichius O
    N Engl J Med; 2008 Dec; 359(25):2725; author reply 2726. PubMed ID: 19092159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.